Core Laboratories N.V. (CLB) Stock Split, History Data
Working capital analysis
In terms of working capital, Core Laboratories N.V. maintains a healthy position.
The total current assets of the company are valued at $223135999.
This represents a growth rate of 5.401% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $15119999, exhibiting a growth rate of -1.996% year-on-year.
The receivables, another significant portion of the current assets, are valued at $123068000.
The year-on-year growth rate for receivables is 15.110%.
The inventory, which forms a critical part of the assets, is valued at $71701999.
This represents a healthy year-on-year growth of 18.624%
On the liabilities side, the company's current liabilities total $88096999.
This reflects a growth rate of -14.581% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
15.12
15.43
17.70
13.81
11.09
13.12
Receavebles
123.07
106.91
96.83
83.19
131.58
129.16
Inventory
71.70
60.45
45.44
38.15
50.16
45.66
Other
13.25
28.92
29.08
30.70
28.40
43.04
Total Current Assets
223.14
211.70
189.06
165.85
221.24
230.98
Acc Payable
33.51
45.85
29.73
23.03
35.61
41.16
Short Term Debt
10.18
11.70
12.34
11.44
11.84
10.40
Other Current Liab
39.66
39.65
40.95
49.83
50.76
33.66
Current Liabilities
88.10
103.14
90.78
89.75
111.59
102.55
Capital Structure
When examining the capital structure of Core Laboratories N.V., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Core Laboratories N.V. has chosen to reinvest in the business rather than distribute as dividends.
